Forthcoming Issue Vol. 19 no. 1 Combination of Aripiprazole and Valproate in Children with Tic Disorders: Case Series

Main Article Content

I Made Wedastra
I Gusti Ayu Indah Ardani
Yunias Setiawati

Abstract

Tic is a disorder characterized by involuntary, repetitive movements and vocalizations that significantly impair affected children's quality of life. These disorders, primarily originating in the basal ganglia, are often misdiagnosed and inadequately treated. The exact etiology of tic disorders is believed to involve a combination of genetic, neurobiological, and environmental factors. Stress is an exacerbating factor leading to an increase in tic frequency and intensity.


This report presented three cases of children diagnosed with tic disorders who exhibited substantial improvement through a combination of Aripiprazole and Valproate. The children, aged 7 to 15 years old, had previously received various treatments with limited success. Upon switching to the combined therapy of Aripiprazole and Valproate, they showed marked improvement in tic severity and associated behavioral issues. The combination treatment underscores the need for further research to validate these observations and to refine treatment protocols for pediatrics with tic disorders.

Article Details

How to Cite
Forthcoming Issue Vol. 19 no. 1: Combination of Aripiprazole and Valproate in Children with Tic Disorders: Case Series. (2024). South African Journal of Child Health. https://doi.org/10.7196/
Section
Case report

How to Cite

Forthcoming Issue Vol. 19 no. 1: Combination of Aripiprazole and Valproate in Children with Tic Disorders: Case Series. (2024). South African Journal of Child Health. https://doi.org/10.7196/

References

Ueda K, Black KJ. A Comprehensive Review of Tic Disorders in Children. J Clin Med 2021;10(11):2479. https://doi.org/10.3390/jcm10112479

Eapen V, Usherwood T. Assessing tics in children. BMJ 2022;e069346. https://doi.org/10.1136/bmj-2021-069346

Greydanus DE, Tullio J. Tourette’s disorder in children and adolescents. Transl Pediatr 2020;9(S1):S94–S103. https://doi.org/10.21037/tp.2019.09.11

Essoe JK-Y, Grados MA, Singer HS, Myers NS, McGuire JF. Evidence-based treatment of Tourette’s disorder and chronic tic disorders. Expert Rev Neurother 2019;19(11):1103–1115. https://doi.org/10.1080/14737175.2019.1643236

Roessner V, Eichele H, Stern JS, et al. European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part III: pharmacological treatment. Eur Child Adolesc Psychiatry 2022;31(3):425–441. https://doi.org/10.1007/s00787-021-01899-z

Billnitzer A, Jankovic J. Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments. Neurotherapeutics 2020;17(4):1681–1693. https://doi.org/10.1007/s13311-020-00914-6

Billnitzer A, Jankovic J. Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments. Neurotherapeutics 2020;17(4):1681–1693. https://doi.org/10.1007/s13311-020-00914-6

Augustine F, Singer HS. Merging the Pathophysiology and Pharmacotherapy of Tics. Tremor Hyperkinetic Mov 2019;8(0):595. https://doi.org/10.5334/tohm.442

Similar Articles

You may also start an advanced similarity search for this article.